Yuli Talyansky

Yuli Talyansky

Auto-generated profile, based on publicly available information

Yuli Talyansky

Universities Space Research Association, NASA Ames Research Center, Moffett Field, CA, 94035, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
YTYuli Talyansky
Yuli Talyansky
TNTravis B. Nielsen
Travis B. Nielsen
JYJun Yan
Jun Yan
UCUlrike Carlino-Macdonald
Ulrike Carlino-Macdonald
GVGisela Di Venanzio
Gisela Di Venanzio
BSBrad Spellberg
Brad Spellberg
Acinetobacter baumanniiis a highly antibiotic-resistant bacterial pathogen for which novel therapeutic approaches are needed. Unfortunately, the drivers of virulence inA.baumanniiremain uncertain. By comparing genomes among a panel ofA.baumanniistrains we identified a specific gene variation in the capsule locus that correlated with altered virulence. While less virulent strains possessed the intact genegtr6, a hypervirulent clinical isolate contained a spontaneous transposon insertion in the same gene, resulting in the loss of a branchpoint in capsular carbohydrate structure. By constructing isogenicgtr6mutants, we confirmed thatgtr6-disrupted strains were protected from phagocytosisin vitroand displayed higher bacterial burden and lethalityin vivo.Gtr6+ strains were phagocytized more readily and caused lower bacterial burden and no clinical illnessin vivo. We found that the CR3 receptor mediated phagocytosis ofgtr6+, but notgtr6-, strains in a complement-dependent manner. Furthermore, hypovirulentgtr6+strains demonstrated increased virulencein vivowhen CR3 function was abrogated. In summary, loss-of-function in a single capsule assembly gene dramatically altered virulence by inhibiting complement deposition and recognition by phagocytes across multipleA.baumanniistrains. Thus, capsular structure can determine virulence amongA.baumanniistrains by altering bacterial interactions with host complement-mediated opsonophagocytosis.

11 April 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
April E. RoncaApril E. Ronca
April E. Ronca
EMEric L. Moyer
Eric L. Moyer
YTYuli Talyansky
Yuli Talyansky
MLMoniece Lowe
Moniece Lowe
SPShreejit Padmanabhan
Shreejit Padmanabhan
RGRuth K. Globus
Ruth K. Globus
Interest in space habitation has grown dramatically with planning underway for the first human transit to Mars. Despite a robust history of domestic and international spaceflight research, understanding behavioral adaptation to the space environment for extended durations is scant. Here we report the first detailed behavioral analysis of mice flown in the NASA Rodent Habitat on the International Space Station (ISS). Following 4-day transit from Earth to ISS, video images were acquired on orbit from 16- and 32-week-old female mice. Spaceflown mice engaged in a full range of species-typical behaviors. Physical activity was greater in younger flight mice as compared to identically-housed ground controls, and followed the circadian cycle. Within 9–11 days after launch, younger (but not older), mice began to exhibit distinctive circling or ‘race-tracking’ behavior that evolved into a coordinated group activity. Organized group circling behavior unique to spaceflight may represent stereotyped motor behavior, rewarding effects of physical exercise, or vestibular sensation produced via self-motion. Affording mice the opportunity to grab and run in the RH resembles physical activities that the crew participate in routinely. Our approach yields a useful analog for better understanding human responses to spaceflight, providing the opportunity to assess how physical movement influences responses to microgravity.

4 October 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
JYJun Yan
Jun Yan
TNTravis B. Nielsen
Travis B. Nielsen
PLPeggy Lu
Peggy Lu
YTYuli Talyansky
Yuli Talyansky
MSMatt Slarve
Matt Slarve
BSBrad Spellberg
Brad Spellberg
Traditional vaccines are difficult to deploy against the diverse antimicrobial-resistant, nosocomial pathogens that cause health care–associated infections. We developed a protein-free vaccine composed of aluminum hydroxide, monophosphoryl lipid A, and fungal mannan that improved survival and reduced bacterial burden of mice with invasive blood or lung infections caused by methicillin-resistant Staphylococcus aureus , vancomycin-resistant Enterococcus faecalis , extended-spectrum beta-lactamase–expressing Escherichia coli , and carbapenem-resistant strains of Acinetobacter baumannii , Klebsiella pneumoniae , and Pseudomonas aeruginosa. The vaccine also conferred protection against the fungi Rhizopus delemar and Candida albicans . Efficacy was apparent by 24 hours and lasted for up to 28 days after a single vaccine dose, with a second dose restoring efficacy. The vaccine acted through stimulation of the innate, rather than the adaptive, immune system, as demonstrated by efficacy in the absence of lymphocytes that were abrogated by macrophage depletion. A role for macrophages was further supported by the finding that vaccination induced macrophage epigenetic alterations that modulated phagocytosis and the inflammatory response to infection. Together, these data show that this protein-free vaccine is a promising strategy to prevent deadly antimicrobial-resistant health care–associated infections.

9 July 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
April E. RoncaApril E. Ronca
April E. Ronca
EMEric L. Moyer
Eric L. Moyer
YTYuli Talyansky
Yuli Talyansky
MLMoniece Lowe
Moniece Lowe
SPShreejit Padmanabhan
Shreejit Padmanabhan
RGRuth K. Globus
Ruth K. Globus
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.